首页 > 专家库
李泰明

领域:生物产业 学校:中国药科大学职称:副教授

1.对糖尿病及其并发症有治疗作用的功能肽研究及新型肽疫苗设计。 2.基因工程技术构建融合蛋白药物及其发酵分离纯化质量控制研究...

具体了解该专家信息,请致电:027-87555799 邮箱 haizhi@uipplus.com

教育背景

日本进修1年

工作经历

项目课题经历

承担多项国家课题

论文、成果、著作等

1.Taiming Li1*(通讯作者).Enhanced antitumor efficacy by combination treatment with a human umbilical vein endothelial cell vaccine and a tumor cell lysate-based vaccine。Tumour Biol. 2013 Oct;34(5):3173-82. SCI

2.Taiming Li*(通讯作者)Improved efficacy of therapeutic vaccination with viable human umbilical vein endothelial cells against murine melanoma by introduction of OK432 as adjuvant.Tumour Biol. 2013 Jun;34(3):1399-408. SCI

3. Taiming L. *(通讯作者)Generation of a Chimeric Plasmin-Resistant Vegf165/Vegf183 (132-158) Protein and its Comparative Activity. Protein Pept Lett. 2013 Aug;20(8):947-54.

4. Taiming Li1*(通讯作者).Immunization with P277 induces vascular leak syndrome in C57BL/6 mice via endothelial damage。Autoimmunity 2010, 43(8)8:654-663 SCI

5. Taiming Li1*(通讯作者).Specific Antibodies Elicited by a Novel DNA Vaccine Targeting Gastrin-Releasing Peptide Inhibit Murine Melanoma Growth In Vivo. American Society for Microbiology. 。Clinical and Vaccine Immunology, 2009,16(7): 1033–1039 SCI

6.Taiming Li1*(通讯作者).Nasal immunization with heat shock protein 65 attenuates atherosclerosis and reduces serum lipids in cholesterol-fed wild-type rabbits probably through different mechanisms.Immunology Letters 2009, 125:40–45 SCI

7. Taiming Li1*(通讯作者).Construction, Expression, Purification and Immunology Effect of an Anti-Atherosclerosis Chimeric Enzyme Vaccine in Escherichia coli。Immunology Letters 2009, 125:40–4。Protein & Peptide Letters,2008, 15:7 SCI

8.Taiming Li*(通讯作者).Study on preparation and unique properties of a novel insulin analogue with N-terminal Arg-4, Pro-3, Lys-2, Pro-1extension at insulin B-chain。Regulatory Peptides. 2009,157(1-3). SCI

9.Taiming Li*(通讯作者)Quantification of recombinant human relaxin-2 (B-29/A-24) in non-pregnant rat plasma using ultra performance liquid chromatography-mass spectrometry Anal. Methods, 2014,SCI

10.李泰明(第一作者)Cloning, expressing of exendin-4 analogue and bioactivity analysis in vivo. Sheng Wu Gong Cheng Xue Bao. 2012 Jul;28(7):877-86

12. 李泰明(通讯作者)Protective antitumor immunity induced by tumor cell lysates conjugated with。diphtheria toxin and adjuvant epitope in mouse breast tumor model.Chinese Journal of Cancer,2012; 31(6),295-305

专利、著作版权等

1.李泰明(第一)。一种Exendin-4类似物。2013授权

2.李泰明(第一);一种具有降血糖作用的新型肽。201310193522.3 公开

3. 李泰明(第一)。一种Exendin-4类似物及其制备方法和应用. 2013公开

4.李泰明(第一)一种人胰高血糖素样肽-2(1-35肽)类似物制备方法。2011 公开CN102190720A

5. 李泰明(第一)人胰高血糖素相关肽-1类似物 2012公开CN102796192A.

6. 李泰明(第一)一种新型血管内皮细胞疫苗及其制备方法。2012公开CN102793914A.

7.李泰明(第二)人胰高血糖素相关肽-2类似物。授权专利号ZL200510039265.2008授权
声明:本站专家信息来源于各高校官网。